- Hiruki Nakamura
- 02 Oct, 2013
- New York City
Stocks in Tokyo declined and the yen advanced for the second day. Investors focused on the immediate impact of the latest stimulus plan and several economists worried that the proposed sales tax increase will dampen consumer spending.
- Marcus Jacob
- 02 Oct, 2013
- New York City
Stocks advanced in Sydney in light volume and new building approvals declined 4.7% in August from July but gained 7% from a year ago. Australian dollar edged higher and commodities prices fell. Mongolian government signaled additional approvals for the delayed Oyu Tolgoi copper and gold mine.
- Nichole Harper
- 01 Oct, 2013
- New York City
Stocks on Wall Street gained as investors reacted calmly to the U.S. government shutdown. Wall Street is betting that the shutdown will be short lived and debt ceiling will be revised as early as next week. U.S. Treasury yields rose to 2.64% and the dollar index drops to an eight month low.
- Mukesh Buch
- 01 Oct, 2013
- New York City
Actuant net swung to a profit. Chrysler said September sales rose 1%, Ford sales climbed 6% and General Motor sales declined 11%. Diamond Foods plunged as net loss widened. NYSE Euronext sold its 12% stake in Qatar Exchange to Qatar Investment Authority. Paychex net climbed 6%.
- Nigel Thomas
- 01 Oct, 2013
- New York City
Ceres Power Loss in the year narrowed. Poundland profit surged 59%. Pure Wafer operating profit for the year surged. Unilever dropped after consumer products maker estimated third quarter sales growth not to exceed 3.5%. Wolseley annual profit surged to
- Hiruki Nakamura
- 01 Oct, 2013
- New York City
Prime Minister Shinzo Abe approved the increase of sales tax to 8% from 5% and proposed $51 billion stimulus plan that includes tax breaks for capital spending. Sales tax increase is the first since 1997. The much awaited tax increase is expected to dampen consumer spending.
- Marcus Jacob
- 01 Oct, 2013
- New York City
Australian stocks traded lower and Reserve Bank of Australia left its reference rate at 2.5%. Home price index in capital cities increased 1.6% in September and new home sales rose 3.4% in August. Australian retail sales rose 0.4%.
- Nichole Harper
- 30 Sep, 2013
- New York City
U.S. market indexes weakened as the government shutdown looms and reticent lawmakers are in no mood to agree on a short term budget. However, larger battle is ahead to revise debt ceiling in the next two weeks. U.S. Treasury yield was stable but the dollar weakened.
- Mukesh Buch
- 30 Sep, 2013
- New York City
21Vianet said Temasek invested $100 million. Brookfield Property to acquire Brookfield Office Properties for $1.7 billion. Lockheed Martin secured order worth $7.8 billion. Philip Morris agreed to acquire 49% stake in Arab Investors-TA for $625 million.
- Nigel Thomas
- 30 Sep, 2013
- New York City
Aryzta profit dropped but group revenue jumped 7% to
- Hiruki Nakamura
- 30 Sep, 2013
- New York City
Stocks in Tokyo closed lower following the sell-off across Asia. Looming U.S. government shut down turned investors cautious. Prime Minister Shinzo Abe is scheduled to announce new economic and tax measures tomorrow. Toshiba Corp plans to cut television operations by half to 3,000.
- Marcus Jacob
- 30 Sep, 2013
- New York City
Australian markets declined after Asian markets fell as the U.S. faces government shut down and rocky negotiations in finalizing short term budget and lift debt ceiling. Private sector credit growth slowed in August in Australia.
- Nichole Harper
- 27 Sep, 2013
- New York City
Broader market indexes extended losses for the seventh day as U.S. lawmakers debate to avoid government shutdown. Market watchers are expecting politicians to strike a last minute deal but a prolonged government closure will trim economic growth. J.C. Penney plans 96 million share offering.
- Mukesh Buch
- 27 Sep, 2013
- New York City
Accenture declined after sales and profit jumped. BlackBerry said loss widened to $965 million. Finish Line surged as revenue and net climbed. Nike soared after profit surged 33%. Nektar tumbled 25% after phase-2 study for arthritis drug failed to meet expectations. Thor net jumped 6%.